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NARRATIVE REVIEW
Congenital Zika Syndrome
Background and Nutrition Care of
Affected Infants
Ann Gaba, EdD, RD, CDN, CDE;
Ghada A. Soliman, MD, PhD, RD
Zika infection of pregnant women can result in infants with microcephaly and other severe birth
defects. With these conditions come a variety of challenges that impair nutritional status. While
Zika infection in the United States remains relatively rare, registered dietitian nutritionists should
be prepared to assess and provide support to affected children. The most common nutrition-
related consequences of Zika infection have some possible nutrition interventions to minimize
their impact. The goal of nutritional care for infants and children with congenital Zika syndrome is
to promote optimal functional capacity and quality of life. Key words: birth defects, congenital
Zika syndrome, feeding, infants, infectious disease, microcephaly, nutrition, Zika virus
Z IKA IS a viral illness which, when con-tracted by pregnant women, can result in
congenital Zika syndrome (CZS). Congenital
Zika syndrome is associated with significant
perinatal morbidity and mortality in infants.1
While this disease is not common in the
United States, registered dietitian nutrition-
ists (RDNs) should be prepared to address
the needs of these infants when they are en-
countered. Optimizing nutritional status can
support better quality of life. A review of the
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literature did not identify any specific guide-
lines or recommendations for the nutritional
assessment or care of infants and children af-
fected by Zika virus infection. However, pub-
lished research about conditions with some
similar challenges, such as cerebral palsy
(CP) and epilepsy, provides some direction
for RDNs encountering infants and children
with CZS.
Zika virus (Zika V) is a blood-borne,
single-stranded, enveloped RNA virus that has
spread throughout the world in a short time.2
As part of an ongoing project investigating
yellow fever, Zika virus initially was isolated
from a sentinel case rhesus monkey with
fever and from the blood of Aedes africanus
mosquitoes at the Zika forest in Uganda in
1947.3 The first Zika infection in a human
was reported in 1964 in Uganda.4 The pa-
tient presented with fever, frontal headache,
rash, and myalgia. Subsequently, serological
studies indicated that the disease had spread
in East and West Africa, as well as parts of
Asia,5-10 and limited to sporadic cases or clus-
ters within populations. In 2007, Zika virus
infection resurfaced with outbreaks in French
Polynesia, Easter Island, and more recently in
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North and South America.11 By 2013, Zika
infection was alarmingly pandemic.12 The
ominous and threatening ability of Zika virus
to infect pregnant women, leading to serious
birth defects in fetuses and newborns, may
be associated with neurodevelopmental con-
ditions in children.1
ZIKA VIRUS PREVALENCE
The World Health Organization (WHO) has
identified 85 countries, territories, and subna-
tional areas reporting an active presence of
the Zika virus as of January 2018.13 These
data show that transmission is ongoing in
North and South America, the Western Pa-
cific region, Southeast Asia, and Africa. The
US Centers for Disease Control and Preven-
tion (CDC) has identified specific countries
with active maternal to infant transmission
of the Zika virus.14 A total of 5716 cases of
adults with Zika virus infection have been re-
ported in the continental United States,15-17
with an additional 37 292 cases in US terri-
tories, chiefly Puerto Rico.18 In addition to
adults, Zika virus–affected infants have been
identified in Florida19,20 and Texas.21
The CDC established the US Zika Pregnancy
Registry in February of 2016. Analysis of their
data so far has indicated that for completed
pregnancies by Zika-infected women, 6% bore
infants with CZS. This figure increased to 11%
for women who were infected in their first
trimester of pregnancy.22
Details of the biology and pathogenesis
of the Zika virus were largely unknown
until 2014. Only a few cases of Zika virus
infection had been observed in humans,
were self-limited, and displayed only mild
symptoms. There had been epidemics of Zika
infection in the Yap Islands in Micronesia in
2013 and in French Polynesia in 2014, but
no major clinical outcomes were reported
from these instances.23,24 Since then, Zika
virus has garnered more clinical and public
health attention due to evidence linking it to
microcephaly in neonates and Gillian-Barre
syndrome in adults.25-29 By May 2017, 48
countries in North, Central, and South
America reported vector-borne transmission
of Zika virus disease.30
Incidence has been estimated at 1.23% of
adult cases.31 This was exemplified by reports
of the outbreak of Zika infection in Brazil in
2015, showing the virus to be associated with
a significantly increased incidence of congen-
ital microcephaly and other birth defects in
infants born to Zika-infected mothers.32,33 A
recent review by Moore et al34 provides a de-
tailed list of anomalies found in infants with
what has come to be called congenital Zika
syndrome.
Although 20% of Zika virus infections are
symptomatic, and for most people, the dis-
ease is mild and resolves within a week, it
remains problematic, as there is no vaccine
against infection.35 The most alarming symp-
toms are the increased risk of birth defects in
pregnant women, particularly if the infection
occurs in early pregnancy. According to the
CDC statistics, 10% of infants with confirmed
Zika infection and 1 in 20 or 5% of infants




Zika virus is a blood-borne pathogen that
is most commonly transmitted to adults by
the bite of an infected mosquito36 or by un-
protected sexual activity with an infected
partner.17,37,38
Eighty percent of infected individuals show
no recognizable symptoms. Symptoms of Zika
infection are generally mild when evident in
otherwise healthy adults39 and may include
fever, joint pain, a bumpy red skin rash, and
conjunctivitis, all of which can be overlooked
or attributed to other causes.40 One case re-
port demonstrated possible optic neuropathy
in an adult and a 17-day old infant, both with
recent Zika viral infection.41 Children aged
12 months to 16 years contracting Zika from
mosquito bites showed a range of symptoms
similar to those seen in adults.42 The aim of
this review is to summarize the complications
of Zika infection during pregnancy with a
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focus on infants with Zika-related neurologi-
cal and developmental symptoms, nutritional
complications of the fetus and newborns, and
the nutrition care management of such cases.
TRANSMISSION AND SYMPTOMS
IN INFANTS
Zika virus has been shown to cross the pla-
cental barrier and infect the developing fe-
tal brain, resulting in damage to the central
nervous system.43 A comparison of 602 in-
fants with Zika infection with 899 infants who
had been ruled out for this disease found that
Zika virus–affected infants had a significantly
higher (P = .004) likelihood of birth before 37
weeks of gestational age, lower birth weight
(P = .0001), and higher mortality (P = .0001).
Mortality rate was almost 4 times higher for
infants with CZS.32 Data from the US Zika
Pregnancy Registry showed that 10% to 15%
of women with laboratory-confirmed Zika in-
fection gave birth to infants with birth de-
fects consistent with CZS.14 The most promi-
nent feature of CZS is microcephaly, defined
as a head circumference that is more than
2 standard deviations below the mean for
age and gender based on normative growth
charts.44,45 It is a clinical finding, not a diag-
nosis in and of itself. The brains of infants with
microcephaly are proportionally smaller than
the brains of unaffected infants,46 and the con-
dition is almost always associated with some
degree of disability.47
A prospective, population-based study
found that head size at 3 months of age was
a strong predictor of mental and psychomo-
tor development at 12 and 24 months.48
Furthermore, a prospective cohort study by
Olusanya49 reported that microcephalic in-
fants who were not exclusively breastfed
were unlikely to experience catch-up growth
when seen for follow-up at 6 to 8 weeks
of age. Together, these findings demonstrate
that microcephaly is an important risk fac-
tor for impaired nutritional status.49 There is
some evidence that infants with Zika infec-
tion and microcephaly may represent only the
most severely affected cases, with some nor-
mocephalic infants also having neurological
impairment.50 In addition to microcephaly,
CZS may also include vision problems, con-
genital contractures, hypertonia, poor suck-
ing, dysphagia, low birth weight, failure to
thrive, hearing impairment, and seizures.51,52
Infants with CZS are at an increased risk of
infantile spasms, a severe form of epilepsy
that may worsen developmental delay.53,54
Evidence indicates that brain and eye anoma-
lies can occur without microcephaly.34 In ad-
dition, an increased incidence of congenital
heart defects has been reported for infants
with CZS.55
While microcephaly is a prominent feature
of CZS, its absence at birth does not rule out
the possibility of congenital Zika virus infec-
tion, Zika-related brain abnormalities, or other
problems.56 Children born to Zika-infected
mothers may experience developmental dis-
abilities later in life. Thus, the number of af-
fected individuals may be underestimated at
present. It is also important to monitor the
children of Zika-infected mothers with peri-
odical serological testing or a urine analysis
for detecting Zika infection.
The WHO examined the risk of Zika trans-
mission via breastfeeding. The WHO reported
that no neurologic damage had been docu-
mented in infants 0 to 23 months who were
infected with Zika after birth. The WHO has
issued interim guidance on breastfeeding for
women infected with Zika.57 These guidelines
state that available evidence suggests that the
“benefits of breastfeeding for the infant and
mother outweigh any potential risk of Zika
virus transmission through breast milk.”57(p7)
The WHO therefore continues to recommend
breastfeeding as the optimal feeding modality
for infants in this setting.57
EFFECTS OF ZIKA INFECTION
ON BREASTFEEDING
Breastfeeding is the recommended mode
of feeding for infants by virtually all entities
issuing guidelines on the subject.58-62 Zika
virus has been detected in both colostrum
and breast milk of infected mothers, and this
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potential route of infection has been
explored.63 Zika is a flavivirus, along with
dengue, Japanese encephalitis, tick-borne
encephalitis, Powassan virus, West Nile virus,
and yellow fever. Viral genetic material from
these sources can be detected in human
milk.64 The CDC lists the possible modes
of transmission as in utero, mosquito bite,
sexual intercourse, blood transfusion, and
possibly breast milk.65 However, further
studies have found that, for Zika, there is
not a sufficient amount of the virus present
in breast milk to transmit the disease from
a mother to her uninfected infant.66,67 Few
studies exist that address breastfeeding
practices for infants with congenital Zika
infection. While Howard et al21 reported that
affected infants required nasogastric tube
feedings due to poor nutrition status and
were discharged with milk formulas, Gieseke
Guevara and Agarwal-Sinha68 indicated that
the infants with CZS were breastfed. Based
on the available literature, it appears that the
severity of CZS varies and feeding practices
need to be adjusted accordingly.
Although there is an increased rate of pre-
natal and neonatal mortality associated with
Zika infection, most infants with CZS have a
life span similar to that of infants with other
neurological impairments.69 Infants and chil-
dren affected with Zika will need ongoing
care; however, gaps in our present knowledge
of the long-term impacts of Zika infection
prohibit an understanding of the full extent
of those needs over a lifetime.70 Bailey and
Ventura71 point out the likelihood of needing
lifelong care and suggest a family-centered ap-
proach through a medical home. This care
will come at a significant cost. One report
showed that the mean length of stay for in-
fants with microcephaly (from any cause) was




In January 2016, the CDC issued guidelines
for clinicians caring for pregnant women with
potential Zika exposure73 and updated these
in 2017.74 They issued an advisory warning
for pregnant women about the risk of travel
to countries where active transmission of Zika
virus occurred.75 Travel updates are posted
periodically on CDC’s travel Web site.76 Zika
was declared to be a “public health emer-
gency of international concern” by the WHO
in February of 2017.76
Because mosquitoes primarily transmit the
Zika virus, areas with tropical climates con-
ducive to high mosquito populations are at es-
pecially high risk. Dissemination in the United
States is a possible threat, especially in south-
ern states.77 Control of mosquitoes as a vector
for Zika is an important preventive measure
and involves hygienic activities such as elimi-
nating standing or stagnant water as a breed-
ing place and maintaining window and door
screens on homes to prevent entry, as well as
the application of insecticides.78
Travel exposures put large urban centers
at risk, as well. The New York State Depart-
ment of Health and the New York City De-
partment of Health and Mental Hygiene ob-
tained data on the prevalence of microcephaly
from all causes in New York State from 2013
to 2015 to establish baseline levels prior to
the introduction of Zika.79 They reported a
prevalence of 4.2 cases per 10 000 live births.
In 2016, New York had the highest number
of travel-related Zika virus cases in the conti-
nental United States.80 For this reason, hospi-
tals in New York City have implemented Zika
prevention and response protocols.81,82 Sim-
ilar guidelines for patient education on Zika
prevention were included in a review article
by Sampathkumar and Sanchez.83 Vaccines
against the Zika virus are under development
as a preventive measure.84,85
PUBLIC AWARENESS
Despite statements from WHO, CDC, and
other organizations, knowledge of Zika pre-
vention by the general public has remained
low. A survey of people in New York
City found that there were significant gaps
in knowledge about Zika, especially as a
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sexually transmitted disease.86 A larger na-
tional survey had similar results.87 A nation-
wide survey of pregnant women in the United
States elicited reports of being worried about
Zika virus infection. Women identified them-
selves as being at risk but had gaps in their
factual knowledge about the disease.88
A ROLE FOR THE RDN
In 2017, an editorial in The New Eng-
land Journal of Medicine pointed out that
new knowledge about the Zika virus and CZS
should be widely disseminated to practition-
ers and applied to improve patient care.89
While it is uncommon for an infant with CZS
to present in a US hospital, RDNs should be
aware of this syndrome and be prepared to
address the needs of these infants when they
are encountered. Marchand and Motil90 sug-
gested that neurologically impaired children
should have ongoing monitoring for nutri-
tional comorbidities as an integral part of their
care.
Care of infants and children with a con-
genital Zika virus infection is not curative but
should consist of supportive care. Ongoing as-
sessment and care should be carried out with
the infant’s individual medical and neurode-
velopmental needs in mind.49,91,92 Further in-
vestigations should seek to understand what
services will be needed by these children as
they grow.93 According to the CDC, because
of the variety of problems that are seen in in-
fants with CZS, individualized care is essential
and requires an interdisciplinary team, includ-
ing an RDN.94-96 Evaluating and maintaining
optimal nutritional status in infants with CZS
are important. Consideration of any food and
nutrition problems that arise is warranted. Ex-
tracting best practices by symptoms from sim-
ilar conditions may provide some guidance
to those responsible for the nutritional care
of these infants. An initial search of PubMed
using the terms “Zika infant” and “congeni-
tal Zika syndrome” was conducted, resulting
in 390 documents. These documents were
evaluated for timeliness and relevance to the
nutrition assessment of infants with CZS. The
findings of this analysis are reported later.
NUTRITION CARE OF INFANTS WITH CZS
As noted earlier, little has been reported
about the details of nutritional care received
by infants with CZS. Cases of 2 infants with
CZS in Texas have been described in detail.21
Both were delivered by cesarean section at
39 weeks of gestation, and both had a low
birth weight, 2.62 kg, and 2.39 kg, respec-
tively. Both infants received care in the neona-
tal intensive care unit, the first for 9 days and
the second for 28 days. Both infants required
nutritional support via orogastric tube due to
poor feeding ability. They were both transi-
tioned to bottle-feeding before discharge, al-
though details of the formula type, concen-
tration, and rate of administration were not
reported. Another case report from Florida
described an infant born at 36 weeks of gesta-
tion, who exhibited severe microcephaly, but
was able to breastfeed successfully.68
CZS FEATURES IMPACTING
NUTRITIONAL STATUS
Low birth weight, poor suckling, dyspha-
gia, developmental delay, movement disor-
ders, and vision and hearing impairment mani-
fest in congenital Zika infection. In spite of the
lack of literature reporting nutritional inter-
ventions for infants and children affected by
CZS, characteristics of this syndrome likely to
impact nutritional status are described in this
section.
Low birth weight
Analysis of 34 infants with CZS in Brazil
reported that their average birth weight was
2.77 kg at an average of 37.7 weeks of
gestational age. Close to 60% of these in-
fants were delivered by cesarean section
and 47.1% were exclusively breastfed.97 Ra-
menghi et al98 point out the increased prob-
ability of malnutrition due to difficulty feed-
ing infants who are very sick and unstable.
Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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Inadequate feeding can result in intakes well
below the recommended dietary intake and
nutritional deficits. Neonatologists generally
agree that one of the goals when caring for
low-birth-weight infants is to achieve satis-
factory growth and functional development.
Inadequate nutrition can result in increased
risk of infectious diseases, lung injury caused
by impaired tissue repair, muscle weakness,




Zika infection in pregnant women can re-
sult in devastating neonatal complications in
their infants. Many of the difficulties seen
with Zika-affected infants are similar to those
of other premature infants, including deficits
in oral feeding ability.100 Infants with neu-
romuscular diseases may be unable to con-
sume enough breast milk or formula to meet
their needs. These infants should be moni-
tored closely for indicators of dysphagia, such
as difficulty breathing with feeding, cough-
ing or choking during feeding, or extended
feeding times.101(p1095) Signs of dysphagia war-
rant an evaluation from a speech and language
therapist. Enteral feeding may be required to
prevent aspiration and to promote adequate
intake.102
Zika-associated outcomes include symp-
toms affecting the digestive system.103 The
most common symptoms are dysphagia, re-
flux esophagitis, constipation, and impaired
gastrointestinal motility. An analysis of 83 in-
fants with CZS found that most could be fed
normally, with 9.6% having gastroesophageal
reflux with aspiration. In some cases, feed-
ing difficulties did not become evident un-
til several weeks or months after birth.104
Saad et al105 noted that around 4 months of
age, sucking and swallowing reflexes disap-
pear, exacerbating dysphagia and increasing
the risk of aspiration. Gastroesophageal re-
flux disease (GERD) is also a common com-
plication in these infants. In a study of older
children (average age of 21 months), more
than 70% had severe difficulty eating and
required a modified diet (with consistency of
mashed, pureed, strained, or liquid). Almost
95% of participants could not use utensils or
drink from a cup.68
A study by Leal et al106 examined 9
infants with CZS referred for evaluation of
dysphagia and found several issues including
choking, coughing, regurgitation, respiratory
infections, and extended feeding time. All of
the infants were evaluated by 3 methods; the
Schedule for Oral Motor Assessment to exam-
ine the oral phase of swallowing; a fiberoptic
endoscopic evaluation of swallowing; and
a videofluoroscopic swallowing study. The
evaluations indicated that liquid foods were
more likely to be problematic than pureed
foods. Most of the infants had abnormal move-
ments of the tongue that contributed to their
dysphagia. They also had difficulty visually
judging how far to open their mouth to take
a bite you need of certain foods, called “jaw
grading.” Interventions included nasoenteric
feeding required by 2 infants and thickened
liquids and purees for the other 7 infants.
Developmental delay
Wheeler et al69,107 reported a follow-up
study of 27 children (13-22 months), looking
at developmental milestones and skills. Chil-
dren in this sample had developmental skills
comparable with infants 6 to 8 months of age.
Less than half were able to drink liquids from
a cup held by a caregiver. Another study of 24
children with CZS (18-24 months) found that
their growth rate was less than expected, and
they exhibited severe neuropsychomotor im-
pairment. All required feeding via gastric tube
and 25% were classified as malnourished.53
Movement disorders
Pessoa et al108 noted that the description
of abnormal neurological findings in reports
about Zika-affected infants is consistent with
a diagnosis of CP. Early onset of involuntary
movements and epilepsy is likely related to
severe brain damage. Having 1 or both of
these neurologic conditions placed them at
risk for malnutrition as well as swallowing
and feeding difficulties.108 Forty-eight infants
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(1-8 months of age) with CZS in Brazil were
examined by de Silva et al.109 Twenty-seven
(56.3%) had involuntary movements and rigid-
ity in the extremities that were absent dur-
ing sleep; 7(14.6%) had dysphagia. Most of
these infants (42, 87.5%) had been born at full
term and only 9 (18.7%) had very low birth
weights.109
A follow-up of 19 infants with CZS enrolled
in the Zika Outcomes and Development in In-
fants and Children study at ages of 19 to 24
months revealed that 14 (79%) had severe mo-
tor impairments; 13 (68%) had hearing prob-
lems; 11 (58%) had vision problems; and 9
(47%) had difficulty with feeding/eating.110
The number and severity of eating problems
may have been underreported, in view of their
other finding that 13 of the 19 (68.4%) had
weights at 1 to 3 standard deviations below
the mean for their age and sex.110
Vision/hearing impairment
A study of 29 infants with CZS and micro-
cephaly reported that 10 (34.5%) had vision-
threatening eye problems.111 In a prospective
case series of 43 infants with CZS seen at clin-
ics in Columbia and Venezuela, all were found
to have bilateral ophthalmic abnormalities.112
Five (12%) had congenital glaucoma, and 38
(88%) had macular or optic nerve manifesta-
tions.
Another case series looking at 32 infants
with CZS found visual impairments in all
of them, with 14 (44%) having diagnosed
retinal and/or optic nerve damage.89 These
authors evaluated the infants to assess the
impact of their visual impairment on their
attainment of the usual milestones of infant
development. They found that these were
negatively impacted. Eight of the infants
(26%) could not make eye contact, and 16
(32%) had no social smile when interacting
with care givers. By 6 months of age, 17 (63%)
were unable to reach for an object presented
to them. Using the same assessment protocol,
this group conducted a subsequent study,
comparing 119 infants with CZS with 85
demographically matched controls.113,114 In
this study, the results for the infants with
CZS were similar to their previous report and
were significantly different (P < .001) from
the control infants. A review on Zika virus
and the visual impairments noted that reports
indicate that between 34% and 55% of infants
with CZS have a visual impairment.113,115-117 It
is recommended that these “children should
have ophthalmic evaluations every 3 months
and a formal evaluation of vision function at 1
year of age.”117(p599) Ventura et al showed that
60 children 9 to 16 months of age responded
well to visual correction with eyeglasses.118
In addition to visual impairment, hearing




Nutrition approaches that have been used
in the assessment and treatment of individuals
with similar challenges could be applied in
children with CZS. Standard laboratory tests
should be included in nutrition assessments.
These children with CZS, especially those ex-
clusively tube-fed, may be at an increased risk
of micronutrient deficiencies.119 A complete
blood count should be evaluated periodically
to identify iron-deficiency anemia, and serum
calcium, phosphorus, and vitamin D levels
be checked to assess bone mineral status.119
Nutritional assessment of a neurologically
impaired child should include a thorough
medical history, a social history, a dietary
intake history, growth and anthropometric
measures, a nutrition-focused physical exam-
ination, observation of intake at a meal, and
other diagnostic studies as needed. Specific
neurological disabilities and their severity,
ambulatory status, and cognitive ability are
also important to evaluate in neurologically
impaired children.120
A number of national and international
organizations have published recommenda-
tions and guidelines for the nutritional
care of children with neurological impair-
ments.90,119,121-125 The issues identified are
similar to those described previously for
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infants and children with CZS. There is a
strong consensus that monitoring the nutri-
tional status of these individuals is a critical
component of their care and should be done
in the context of an interdisciplinary team.
Most of the literature on which these are
based is derived from studies of infants and
children with CP and/or epilepsy. The gen-
eral picture with general neurological impair-
ment can include issues with feeding, gastroe-
sophageal reflux, dysphagia, constipation, os-
teopenia, micronutrient deficiencies, growth
failure, and cognitive impairment limiting the
ability to communicate hunger or satiety to
caregivers. The goal of any planned nutri-
tion intervention should be to optimize qual-
ity of life while promoting adequate growth
and development and optimizing nutritional
status.90
The majority of children with neuro-
logical impairment have some degree of
dysphagia.126 Irregularities in movements by
the jaw and/or tongue may interfere with
chewing and swallowing.127,128 These can re-
sult in poor intakes and a diminished rate
of growth and development. Evaluation by
a speech-language pathologist can determine
the type and severity of dysphagia and pro-
vide guidance as to optimal consistency of
foods and fluids. The RDN then operational-
izes the speech-language pathologist recom-
mendations to provide a diet that meets the
individual’s needs and preferences.
Energy requirements are often difficult
to determine in neurologically impaired
individuals. Assessment of body composition
and indirect calorimetry should be employed
when available.124,125 Serial measurements of
growth, weight, and anthropometrics should
be monitored, and adjustments to feeding
made as needed.90 For those unable to meet
their nutritional needs via an oral diet, enteral
nutrition support is recommended. A 5-year
retrospective study of malnourished, neuro-
logically impaired children (aged 4 months
to 18 years) found that most improved
their nutritional status and attained catch-up
growth after percutaneous endoscopic
gastrostomy (PEG) placement and enteral
feeding with a standard polymeric formula
at a rate equal to their estimated energy
needs.129
Gastroesophageal reflux disease affects up
to 75% of children with neurological im-
pairment and creates an increased risk of
aspiration.126 Feeding thickeners have been
shown to be of benefit for some infants with
GERD.130 Children with GERD are given the
same advice as adults, that is, to avoid foods
known to potentially worsen reflux, such as
acidic, spicy, or high-fat foods.126 The North
American Society for Pediatric Gastroenterol-
ogy, Hepatology and Nutrition has published
extensive guidelines on evaluation and treat-
ment of GERD in pediatric patients.129
Herrera-Anaya et al examined nutritional
status in a population of children with CP.131
They found a high prevalence of malnutrition
in the children with the lowest motor func-
tion, based on WHO criteria. Nutrition-related
problems that were identified included dys-
phagia, gastrointestinal reflux, and aspira-
tion, similar to that described in infants with
CZS. This suggests that nutrition care rec-
ommended for infants and children with CP
may also be applicable to those with CZS.
A commentary by Leandro in Developmental
Medicine & Child Neurology pointed out the
similarity between symptoms of CP from all
sources and symptoms of CZS.132
Attention to any potential drug effects is
also an important part of the nutrition assess-
ment with CZS. Neurologically impaired chil-
dren may be taking medications for seizures,
drooling, or other issues that can cause a de-
crease in appetite, dry mouth, constipation,
or other problems that impact intake.128
Finally, enteral nutrition support could be
used if the infant’s nutritional needs cannot
be met orally. Minar et al133 showed that PEG
tube placement could be safely done in 40 in-
fants with dysphagia, who had a gestational
age of 23 to 41 weeks and birth weights be-
tween 2.1 and 5.6 kg. Another study by Mac-
chini et al134 showed similar results. Human
breast milk or infant formula is recommended
for children younger than 12 months, with
pediatric feeding formulas thereafter.124
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CONCLUSIONS
Given the consequences of CZS, the pre-
vention of Zika infection is paramount in
minimizing the number of infants affected
by this disease. The CDC has provided guid-
ance for the general public on how to avoid
Zika infection.135 However, the likelihood of
additional severely affected infants and chil-
dren remains a challenge, given that there is
no vaccination available to prevent the dis-
ease. Registered dietitian nutritionists should
be prepared to engage in the multidisciplinary
care that is required. In the absence of any
evidence-based directives for practice on the
nutrition assessment, intervention, referral,
monitoring, and evaluation of infants with
CZS, lessons learned from infants and children
with other neurological disorders can provide
some guidance.
An assessment of an infant or a child with
CZS must include an examination of any
difficulty with feeding, including dysphagia,
gastrointestinal reflux, and adequacy of
intake, as well as weight and developmental
status. Consultation with a speech-language
pathologist is recommended when symptoms
of dysphagia are present. Where appropriate,
the occupational therapist may suggest adap-
tive equipment to promote independence.
Diet modifications or nutrition support to
address identified problems should be im-
plemented and family caregivers educated as
appropriate. Challenges due to visual and/or
hearing impairment and developmental
delays may also impact nutritional status
with CZS. As the child gets older, these
problems are likely to create ongoing issues
with self-feeding. Finally, when adequate
intake to maintain growth and development
is not possible via an oral diet, enteral
nutrition support has been shown to be a
viable alternative in infants with neurological
impairment.
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